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Determinants of 6-Month Mortality in Survivors
of Myocardial Infarction After Thrombolysis R isk assessment in survivors of acute myocardial infarction has been the subject of several investigations during the past three decades. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Since the late 1970s, most studies have focused attention on the pathophysiological determinants of prognosis and their interactions, leading to an impressive accumulation of new data concerning postinfarction prognosis. 13, 14 However, current knowledge of risk as-sessment essentially relies on studies carried out before the widespread application of thrombolysis. Thus, it still needs to be determined whether and to what extent available information and proposed criteria of prognostication are applicable in the thrombolytic era. Furthermore, the cumulative benefit resulting from early intravenous thrombolysis and other pharmacological treatments is likely to have modified risk strata size and mortality among patients recovering from acute myocardial infarction, making the value of previous risk stratification schemes uncertain. Therefore, within the framework of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 trial,1S a prognostic study was planned to reassess the determinants of mortality risk in survivors of acute myocardial infarction in the thrombolytic era. The design of this trial was intended to reflect as far as possible the diagnostic standards currently used in large routine clinical practice, thereby making it possible to set up an unusually large prognostic data base concerning more than 10 000 postinfarction patients discharged alive from the hospital who had been enrolled over a relatively short time from February 1988 to July 1989 in 223 clinical centers.
This report describes the results of the prospective analysis of the risk factors for mortality in the multicenter postinfarction population of the GISSI-2 trial.
Methods

Study Patients
The 10 219 hospital survivors considered in this report had been enrolled in the GISSI-2 study, a factorial, randomized open trial designed to compare the benefits and risks of two thrombolytic agentsstreptokinase and alteplase -in patients with acute myocardial infarction. The patients also were randomized to receive subcutaneous heparin or usual therapy. Exclusion criteria, the method of randomization, procedures for the administration of trial medications as well as guidelines for the recommended treatments have been reported previously. 15 Patients were eligible for enrollment in GISSI-2 (1) if they had chest pain accompanied by ST segment elevation of 1 mm or more in any limb lead of the ECG and/or of 2 mm or more in any precordial lead; (2) if they had been admitted to the coronary care unit within 6 hours from the onset of symptoms; and (3) if they had no clear contraindication to the fibrinolytic treatments and/or to heparin.
The patients included in this data base study were those in whom a diagnosis of definite acute myocardial infarction was centrally validated relying on two of the following three criteria: (1) a prolonged ischemic chest pain; (2) the new appearance of abnormal Q waves with evolutionary ST and T wave changes on serial tracings; and/or (3) enzymatic evidence, as indicated by an elevation of total serum creatine kinase to twice the upper limit of normal values. Data Collection Before randomization, a set of demographic and historical variables was collected prospectively on each patient. In addition, individual information on the clinical course, major clinical events, other treatments during hospital admission and at discharge, and laboratory examinations was collected on a single form. This form together with three ECGs (taken at set intervals, namely, at entry, after 4 hours, and at discharge from the hospital) had to be sent to the coordinating center for review of the completeness and consistency of data and for central computer analysis of the ECG. ECG and Special Tests Concomitant signs of anterior or lateral and inferior myocardial infarction without a history of previous infarct were considered evidence of multiple-site infarct. The development of new Q waves, 0.03 second in duration, was taken as evidence of a "Q wave" infarction, and the presence of serial ST and T wave changes, in the absence of new Q waves in the predischarge ECG, was judged to indicate a "non-Q wave" infarction. Patients with R/S .1 in leads V, to V2 were assigned to the "Q wave" group.
A two-dimensional echocardiographic examination was done to assess segmental left ventricular systolic function just before discharge from the hospital (approximately 2 weeks after the onset of infarction). The ejection fraction was calculated from left ventricular two-dimensional tomograms either by area-length method or by modified Simpson's rule.'8 Evaluation of the segmental left ventricular performance pattern was used to generate an infarct size index expressed as the percentage of akinetic or dyskinetic segments. This functional index indirectly reflects the left ventricular function as it is dependent on the degree of overall myocardial damage caused by ischemia or infarction. For wall motion analysis from standard two-dimensional tomograms (parasternal, apical, and subcostal views), the left ventricle wall was divided into 11 segments according to the model originally proposed by Edwards and colleagues, modified considering the apex as a single segment. '9 An echocardiographic examination was not available for 18.6% of the patients, mostly because of poor echogenicity or logistic reasons. A determination of ejection fraction was available in 27.5% of the patients.
A symptom-limited exercise stress testing was performed, whenever possible, within 30 days from randomization according to standards and guidelines for exercise testing provided by an Italian ad hoc committee.20 Approximately 38% of the patients were excluded from stress testing on clinical grounds.
A 24-hour Holter monitoring was performed near hospital discharge in 83% of the patients. The remainder of the population did not have a Holter recording for logistic or technical reasons. Premature ventricular complexes were categorized according to their mean frequency per hour, corrected for data loss, and presence of repetitive forms (couplets, runs, or ventricular tachycardia).
Quality Control
Central quality control of special tests (ie, the 24hour ECG recordings, the exercise stress ECGs, and the tape recordings of echocardiographic examinations) was ensured by checking a randomly selected sample of about 10% of the whole examinations of each laboratory by a staff of experienced cardiologists who were blinded to study treatments. Quality control was meant to verify the correct assignment of patients according to prespecified risk variable presence or absence. 
Risk Variables
For the purpose of this data bank study, an ad hoc committee developed written, a priori hypotheses concerning risk factors for mortality, relying on literature review and consensus among the members of the committee.
The variables analyzed included data from the history, ECG, hospital course, and special tests. The following historical and demographic variables were selected: advanced age (more than 70 years), female sex, history of angina (of more than 1 month's duration before the index infarction), history of previous myocardial infarction, history of treated hypertension, or insulin-dependent diabetes mellitus.
Some variables related to the hospital course. Early left ventricular failure was defined as either Killip class of more than II on admission or the new appearance of symptoms and signs of left ventricular failure within day 4 after entry in the cardiac care unit. Late left ventricular failure was defined as the first appearance or persistence of symptoms and signs of left ventricular failure beyond the fourth day of hospitalization. For the diagnosis of left ventricular failure, at least two of the following signs or symptoms were required: bibasilar pulmonary rates, a third heart sound, dyspnea, or radiographic evidence of pulmonary congestion. Early spontaneous postinfarction angina was defined as the occurrence of a typical ischemic chest pain manifesting at rest or at minimal exercise during the hospital stay, 24 hours or more after randomization; transient ST segment depression or elevation of 1 mm or more or inversion or pseudonormalization of the T wave during the episode of chest pain also was required for this diagnosis.
From special tests the following variables were generated. Recovery-phase left ventricular dysfunction was defined as an echocardiographic left ventricular ejection fraction of less than 0.40 or, whenever an ejection fraction determination was not available, a percentage of akinetic or dyskinetic myocardial segments of 36% or more; the latter indicator of left ventricular dysfunction was selected assuming that its adverse impact on survival was roughly similar to that of an ejection fraction of less than 0.40. This assumption was later corroborated by the observation of a 10.7% 6-month mortality rate among patients with a left ventricular ejection fraction of less than 0.40 and a 9% mortality rate among patients with a percentage of injured segments of 36% or more. Electrical instability was defined as the presence of frequent (10 or more per hour) premature ventricular beats and/or couplets, runs, or ventricular tachycardia during monitoring. The development of angina during exercise or the appearance of ST segment depression of 1 mm or more 0.08 second after the J point, as determined by the clinic physician, was taken as evidence of a positive exercise test (ie, effort residual ischemia). Exclusion from exercise stress testing for both cardiac and noncardiac clinical reasons was selected as an additional exercise test-related variable in view of previous studies that consistently showed the process of being excluded for clinical reasons from exercise testing to identify a high-risk group of postinfarction patients.21 From the ECG, two variables were derived: anterior site of infarct (ie, a Q wave infarct categorized as either anterior, anterolateral, or anteroinferior) and a QRS score of more than 10, assumed to be a marker of extensive infarction.22 A decision was made to exclude from this analysis the variable concerning the type of infarction (non-Q wave versus Q wave) as the subset of non-Q wave infarcts included in this data base (ie, those presenting with ST segment elevation) did not exhibit different survival probabilities compared with the Q wave group at preliminary screening of relevant risk determinants.
Follow-up
Enrolled patients were seen during a clinic visit at 6 months after randomization. In this analysis, risk assessment is based on all-cause mortality, including fatal myocardial infarction.
A clinical follow-up was available for 88.6% (9049 of 10 219) of the patients discharged alive. For the remainder of the population not traced by clinical centers, information on survival had to be secured through the census bureaus of the towns of residence by prepaid return mail forms.
Statistical Analysis
All patients were included in the study regardless of missing data. The association of each variable with survival was assessed first by calculating the crude odds ratio and the 95% CI. Variables significantly associated with survival in this univariate analysis then were included in a Cox regression model.23 A model including the same variables but restricted to the 8319 patients for whom the echocardiographic indicator was available then was fitted to better control the role of this variable as a confounding factor. The K statistic was calculated as a measure of agreement for the laboratory examination.
Results A total of 10 407 patients were discharged from the hospital with a diagnosis of definite acute myocardial infarction (Fig 1) . Follow-up information concerning vital status was unavailable for 188 patients (1.8%). The baseline characteristics of the 10 219 patients included in this analysis are reported in Table 1 .
Mortality Data
The in-hospital and cumulative 6-month mortality rates of GISSI-2 patients with confirmed acute myocardial infarction were 9.4% and 12.7%, respectively. Among the 10 219 hospital survivors followed-up (98.2% of the total), 359 death events were observed by 6 months (a 3.5% mortality rate). This mortality rate is significantly lower than that observed in the corresponding cohorts of the GISSI-1 trial, respectively, allocated to usual treatment (5.1%, P<.001) or streptokinase therapy (4.6%, P<.01) ( Fig 2) . Notably, such a mortality rate cannot be attributed to a lower mean age (61 years for GISSI-2 patients versus 60 years for their GISSI-1 counterparts).
Medications and Revascularization Procedures During Hospital Admission and Follow-up
The cardiovascular treatment regimen and the incidence of revascularization procedures are reported in Table 2 . At the time of hospital discharge, nearly three fourths of patients were taking aspirin (altogether slightly more than 80% were on antiplatelet drugs), one fourth were taking j3-adrenergic-blocking agents, and nearly one third were taking calcium antagonists. The corresponding values at 6-month follow-up were somewhat lower for aspirin, slightly lower for (-blockers, and higher for calcium antagonists. Overall, these values compared with the lower percentages observed in the GISSI-2-like cohort of the GISSI-1 trial, who were allocated to streptokinase treatment, indicate an increase in the use of antiplatelet agents (81% versus 47%, P<.001 at hospital discharge; 76% versus 46%, P<.001 at 6-month follow-up) and (3- or to streptokinase treatment (GISSI-1 SK). The 3.5% rate observed among GISSI-2 patients is significantly lower than that found among GISSI-1 patients (GISSI-1 C, 5.1 %o; P<.OO1; GISSI-1 SK, 4.6%o; P<.O1). nary angioplasty (PTCA) or coronary artery bypass graft surgery (CABG) following the index event made up only 7% of the population. As expected, higher incidence rates of revascularization procedures were seen in patients with residual ischemia. Cumulative rates of 20.1% and 14.7%, respectively, were observed among patients with early postinfarction angina (in-hospital rates were 2.6% for PTCA and 1.8% for CABG; postdischarge rates by 6 months were 4.0% for PTCA and 11.7% for CABG) and with a positive exercise test (in-hospital rates were 1.3% for PTCA and 0.7% for CABG; postdischarge rates by 6 months were 4.5% for PTCA and 8.2% for CABG).
Univariate Analysis
A univariate analysis of the associations between selected variables and outcome during the 6-month follow-up is shown in Table 3 . Except for the variable reflecting effort residual ischemia (ie, a positive exercise test), all of the baseline clinical features were predictive of a fatal outcome. The factors that showed the most significant associations with all-cause mortality were the exclusion from the exercise test for both cardiac and noncardiac reasons, risk predictors reflecting or measuring mechanical left ventricular dysfunction, and advanced (more than 70 years) age. Regarding echocardiographic ejection fraction (available in a representative sample of slightly more than 2800 patients with an overall mortality rate of 3.4%), the observed values, graded into five categories, were related to all-cause mortality. There was a progressive increase in 6-month mortality as the ejection fraction declined below 0.40 with the subgroup with the most severe impairment of systolic function exhibiting a 15.2% mortality rate (Fig 2) .
Multivariate Analysis
On multivariate analysis, performed according to the Cox model,23 of the 15 selected variables, 8 were retained as independent predictors of outcome, namely, the exclusion from the exercise test, early and late (beyond day 4) left ventricular failure, recovery-phase left ventricular dysfunction, advanced (more than 70 years) age, electrical instability, previous myocardial infarction, and a history of treated hypertension ( Table  4 , top). The most potent risk predictors (ie, those associated with a relative risk of more than 2) were two variables relating to the extent of myocardial damage after infarction (early left ventricular failure and recovery-phase left ventricular dysfunction) and a complex indicator such as the process of being excluded from the exercise test for both cardiac and noncardiac reasons.
Surprisingly, indicators of residual myocardial ischemia (ie, early postinfarction angina and a positive exercise test) did not appear to be risk determinants (Table 4, bottom) . A similar conclusion applies to other demographic (female sex), historical (history of angina and history of diabetes mellitus), and ECG (anterior location of infarct and a high QRS score) variables.
Further Analysis in Patients With Echocardiographic Indicator Available
To further investigate factors actually associated with increased risk of death, a separate multivariate analysis was performed on the subpopulation of 8315 patients with an objective measure of left ventricular systolic function available. Univariate analysis. On univariate analysis, all of the baseline characteristics were still predictors of outcome with the sole exception represented by the variable for ischemic response to the exercise test associated with only a trend toward a greater risk of dying. Interestingly, 429 of 718 patients (59.7%) with late left ventricular failure did not exhibit the echocardiographic marker of left ventricular dysfunction.
Regarding eligibility for exercise test, in Table 5 are reported historical and clinical data for patients with and without an exercise test. Among patients not exercise tested, not only was a higher prevalence of female sex and advanced age present, but also both the clinical history and the in-hospital course after the index infarction were more complicated.
Low-risk subgroups. In this population, eligibility for exercise test, in the absence of clinical or echocardiographic variables reflecting left ventricular dysfunction, identified a low-risk group with a 6-month mortality rate of 0.86%. This subgroup of patients made up 53% (4422 of 8315 patients) of the population considered. Moreover, patients less than 70 years old and without any clinical or echocardiographic indicator reflecting left ventricular dysfunction had a low mortality of 1.2% (5198 of 8315 patients, making up 62.5% of this population) that decreased to 0.8% for those exercise tested (4068 of 8315 patients, making up 49% of this population).
Multivariate analysis. On multivariate analysis of the eight factors that were originally found to be significantly correlated with mortality, seven were still retained as independent risk indicators ( Table 6, top) . Only a history of previous infarction no longer made a significant and independent contribution to mortality in this multivariate analysis in which the entire subpopulation was classified according to a dichotomized laboratory measure of left ventricular function ( Table 6 , bottom). Among the seven variables of prognostic importance, the variable for arrhythmia rather than advanced (more than 70 years) age ranked fourth behind ineligibility for exercise stress testing and two most potent indicators of left ventricular dysfunction. Late left ventricular failure and a history of treated hypertension were the variables less strongly correlated with a poor survival. Interestingly, late left ventricular failure was associated with a relative risk slightly lower than that observed in the first analysis ( Table 6 , top).
Quality Control
The results of the quality control of the laboratory examinations are reported in Table 7 . Figures concerning the overall proportion of agreement (po values) have been adjusted for the agreement expected by chance alone (K values). The K statistic shows excellent degrees of agreement for variables relating to ventricular arrhythmias and exercise-related ischemia and highly satisfactory agreement for echocardiographic markers of left ventricular dysfunction. 25 Discussion The most striking finding of this population-based prognostic study is the 3.5% all-cause mortality observed during the first 6 months after discharge, which would denote according to previously established criteria of prognostication22 only a moderate-to-low risk. Not only is this 6-month rate distinctly lower than that found in studies carried out in the 1970s through the 1980s, ranging approximately from 6% to 10%26-29 but also suggests a more recent decline in postinfarction mortality in comparison with the death rate of 4.6% observed both in the GISSI-2-like cohort of the GISSI-1 trial (Fig 2) and in the intervention arm of the Anglo-Scandinavian Study of Early Thrombolysis study.0 This fact confirms and extends the concept of a historical trend toward a reduction in 1-year mortality after infarction,28,31 which is likely to reflect new therapeutic modalities32,33 (ie, increasing use of f-blocker and antiplatelet agents like in GISSI-2) and risk factor modification. 34 Of note, despite the low cumulative rates of PTCA and CABG observed in the GISSI-2 population during both hospital admission and the 6-month follow-up, patient survival does not appear to be much lower than that found in smaller series of patients undergoing aggressive diagnostic and therapeutic strategy, for whom the average age and therefore the average risk were lower. 35'36 In this population, which should be taken as a highly representative sample of thrombolysed patients recov- the exclusion from exercise testing for clinical reasons was selected as a variable in a multivariate analysis, and it proved to be the number one predictor of outcome, associated with a relative risk of similar magnitude irrespective of whether cardiac or noncardiac reasons Patients not performing an exercise test were older, were more ill, and exhibited a higher frequency of complications in comparison to those who were exercise tested. With respect to ineligibility for noncardiac reasons, it must be recognized that an unrecorded variable such as peripheral arterial disease, known to be a strong predictor of subsequent mortality,38 might have contributed to the observed excess of mortality. Thus, exclusion from the exercise test appears to be an empiric index that incorporates the cumulative risk resulting from overlapping of known adverse prognostic factors and their detrimental interactions.
Two variables relating to the extent of postinfarction left ventricular damage (ie, early left ventricular failure and recovery-phase left ventricular dysfunction) are the next strongest independent predictors of mortality with relative risks of similar magnitude ( Table 6 , top). It should be noted that our definition of early left ventricular failure does not fit closely the more conservative one (advanced rales in cardiac care unit) adopted by others,8 and this may help explain the lower relative risk that we found. The independent prognostic information carried by clinical or radiographic evidence of early left ventricular failure and an objective measure of left ventricular function, obtained near hospital discharge, confirms the findings of other studies carried out before the use of thrombolytic therapy6'8'39 and demands a better understanding of the still-debated mechanism responsible for pulmonary congestion following myocardial infarction. [39] [40] [41] In keeping with current knowledge,8'42'43 the analysis of left ventricular ejection fractions, available in a representative sample of 2813 patients, shows an inverse curvilinear relation between ejection fraction and mortality with an upturn in mortality occurring at values less than 40% (Fig 3) . This hyperbolic trend does not support the suggestion of a different curve slope shifted down to the left, which would be typical of patients recovering from myocardial infarction after thrombolysis.4" It is fair to recall that as yet such a curve slope has been described only by Thrombolysis in Myocardial Infarction (TIMI)-II investigators in a subset of relatively low-risk patients and thus cannot be taken as representative of the overall study population. 45 It has been suggested that the application of early intravenous thrombolysis in the general population would change risk strata size,46 thereby influencing the overall outcome of postinfarction patients. In line with those expectations, the 13% incidence of early left ventricular dysfunction observed in this population ap-pears lower than that found in another data base, regardless of the criteria (clinical or radiographic) applied to define this complication. 39 In terms of categories of left ventricular function, an indirect comparison of GISSI-2 data with those of some previous studies appears to indicate a decrease in the proportion of patients with depressed (less than 40%) left ventricular ejection fraction, when the observed 20% value is confronted with the higher corresponding figure of more than 30% reported in the prethrombolytic era.l24042 However, it is unclear whether this seemingly lower proportion of patients with impaired left ventricular function may be entirely ascribed to the application of thrombolytic therapy as controlled studies have shown that the magnitude of the effect of thrombolytics on left ventricular ejection fraction is relatively small. 47 Moreover, even the apparent benefit of early thrombolytic treatment would be partially masked by the so-called time to treatment paradox.48 Indeed, according to this hypothesis, early reopening of the infarctrelated vessel would save a number of individuals with initial extensive myocardial damage who otherwise would have died, thereby increasing the proportion of infarct survivors with poor left ventricular function.
Surprisingly, in multivariate analyses, a third indicator of left ventricular dysfunction (ie, late left ventricular failure) was retained as an independent risk predictor even when an echocardiographic measure of left ventricular function was available for the entire population (Tables 4, top, and 6, top) . Notably, nearly 60% of patients with late left ventricular failure did not exhibit the selected echocardiographic marker of left ventricular dysfunction. However, it is well known that patients with coronary artery disease may present with heart failure symptoms even in the absence of significantly depressed ventricular systolic function49 and exhibit a high incidence of abnormal diastolic function.50 Therefore, it is reasonable to assume that in a population of postinfarction patients the less pronounced degrees of left ventricular systolic dysfunction or concurrent altered patterns of left ventricular diastolic filling carry important prognostic information, which helps refine risk prediction even when other stronger variables reflecting reversible or irreversible extensive myocardial damage are entered in a multivariate analysis.
Variables reflecting residual myocardial ischemia were not of prognostic value regarding all-cause mortality. However, this finding needs to be placed in context. Regarding myocardial ischemia on the exercise test, a possible confounding factor is represented by those patients (14.7%) who had by 6 months either PTCA or CABG. However, other studies without such confounding factors5152 also have failed to show ST depression during the exercise test to have prognostic relevance. Moreover, a recent survey article using metaanalytic techniques showed that exercise-induced ST segment depression during postdischarge or maximal testing did not predict outcome.2' Recently, other risk stratification schemes have proposed to use a work load criterion to define a positive test of prognostic relevance instead of the less stringent criteria based on ST segment shifts alone. 22, 46 Therefore, on the basis of this data base study, in which a mere qualitative variable (ie, positive exercise test) was multivariately associated with a trend toward an increased risk, the possibility cannot 30 40 So 60 70 ECHOCARDIOGRAPHIC EJECTION FRACTION (%) be excluded that an indicator reflecting severe exerciseinduced ischemia might predict reduced survival. The lack of an association between early angina and death in multivariate analysis runs counter to currently held views. 22, 46, 53, 54 This lack of association could be attributed at least in part to the protective effect of revascularization procedures, as a 20.1% cumulative rate of PTCA and CABG was observed in patients with early angina. Nonetheless, other factors must be taken into account. Although ongoing or recurrent postinfarction ischemia causes serious concern and generally is believed to imply a poor outcome, it is fair to recall that available studies have reached conflicting conclusions as to the prognostic implications of postinfarction angina.14 Of note, in the MPIP study in which ECG signs of ischemia were not required as a qualifying criterion, only high-frequency angina (a relatively uncommon occurrence) carried a significant and independent risk for subsequent cardiac death.55 Unlike the results of single-center studies,56'57 in this data base study postinfarction ischemia defined by ECG criteria was not a predictor of mortality. Evidence is accumulating that postinfarction angina has a wide clinical spectrum with different patient subsets ranging from very high-risk groups (as those described by some studies carried out in tertiary referral centers)56-58 to the lower-risk category unassociated with ECG signs of ischemia.59 Also, it must be underscored that the 11% incidence of postinfarction angina found among GISSI-2 patients, which is lower than previously observed,46,56,57 is likely to reflect the protective effect of increasing ,3-blocker and antiplatelet administration following acute myocardial infarction.1560-62 Besides reducing the incidence of postinfarction angina, this therapy might even determine a category-specific less serious profile of risk.
The presence of frequent and complex ventricular arrhythmias during 24-hour ECG monitoring is confirmed among thrombolysed patients as an independent marker of increased mortality. The approximate 33% frequency of complex ventricular ectopic beats observed among patients who underwent 24-hour ECG monitoring is somewhat lower than that reported in previous data bases63,M (range, 36% to 40%) and suggests that improved management of acute myocardial infarction has reduced the incidence of ventricular arrhythmias.
This suggestion appears to be in line with the recent observation of a lesser incidence, after thrombolysis, of other markers of electrical instability such as late po-tentials6566 and inducibility of ventricular tachycardia. 67 Advanced (more than 70 years) age proved to be an independent predictor of postdischarge mortality that was nearly as strong as the variable for arrhythmia (Tables 4, top, and 6, top) . The basis for this association, also found in other studies,25,7,l1,68-7 is still unclear. Although it cannot be excluded that age may act as a surrogate for an unmeasured risk factor such as the extent of coronary artery disease,69 it is reasonable to assume that the effect on mortality of this biological variable cannot be "adjusted away" because of the complex detrimental interactions resulting from age-related changes in cardiovascular structure and function.72 '73 Unexpectedly, a history of treated hypertension made an independent, although weak, contribution to the 6-month mortality risk. Although it is known that hypertension worsens the prognosis of infarct survivors,7,74-79 available data either refer to follow-up periods longer than that considered in this report or have not been adjusted for other important variables. Therefore, it can only be speculated that a history of antihypertensive medication before the index infarction se-20. The results of our multivariate analyses concerning a history of prior myocardial infarction may help clarify the prognostic information carried by this variable (Tables 4, top, and 6, top) . As prior infarction reflects fixed, permanent tissue loss, its impact on mortality is already incorporated, when available, by laboratory measures reflecting cumulative myocardial damage. 40 Interestingly, female sex did not make an independent contribution to the 6-month mortality risk. Although this finding is in disagreement with the conclusions of two recent studies,80,81 it is fair to recall that with regard to long-term outcome after hospital discharge, the majority of available studies either did not indicate female sex as an independent predictor of mortality2,4 '5'11'82-84 or showed even a better prognosis in women. 7, [85] [86] [87] Anterior location of infarct did not emerge as an independent risk predictor. Previous studies have reached conflicting conclusions as to the prognostic relevance of this variable independent of infarct size.88-90 It has been suggested that because of the complexity of cardiac topography,91,92 a similar loss of myocardium after an anterior injury would confer a worse outcome than that occurring after an inferior injury. This might reflect the greater propensity of an anterior injury to result in acute infarct expansion and postacute progressive ventricular remodeling, thereby leading to a more complicated follow-up course and a higher mortality risk. 90'93'94 However,  it is worth noting that the findings of some data base studies in which anterior site of infarct was not found to be an independent risk predictor do not support the attractive hypothesis of a particular response to infarction of the anterior myocardial being a critical determinant of outcome. 8, 95, 96 In keeping with other studies,2 '5,7,14,76,97-99 the findings of this data base do not confirm previous data regarding the independent prognostic significance of other variables such as a history of previous angina,100-102 a history of insulin-dependent diabetes,103 and high QRS score. 17, 104 Low-Versus High-Risk Subsets Among the 8315 patients with echocardiographic data, 5198 who were less than age 70 and had no indicator of left ventricular dysfunction (62.5% of the population) had a distinctly low mortality rate of 1.2%. Moreover, regardless of age, patients with no indicator of left ventricular dysfunction who were eligible for the exercise test (53% of the population) had a mortality rate as low as 0.86%.
However, these values must be compared with those at the other end of the spectrum, where mortality figures approaching or exceeding 10% are found among patients with echocardiographic evidence of left ventricular dysfunction near hospital discharge or with left ventricular failure. In these high-risk subsets, a more aggressive diagnostic and therapeutic strategy might improve survival, thereby limiting further the average risk of infarct survivors.
Conclusions
The survival probabilities of the population described in this report indicate that over only 5 years, a 31% reduction in mortality has been achieved among survivors of myocardial infarction seen within 6 hours from symptom onset (Fig 2) despite a rather low cumulative incidence of revascularization procedures. This improvement, reflecting both changes in risk strata size and increasing use of secondary prophylactic measures, demonstrates that the application in a countrywide clinical practice of the results of large-scale trials32'33'47 translates into epidemiologically and clinically relevant benefit.
It is hoped that ongoing trials105106 will provide a definite answer to whether therapeutic strategies oriented toward the prevention of left ventricular dysfunction may further improve the survival of postinfarction patients. 107 Collaborators and Participating Centers GISSI-2 Steering Committee G.A. Feruglio, A. Lotto, F. Rovelli, P. Solinas, L.
Tavazzi, G. Tognoni.
